Abstract:Deciphering information hidden in the gene expression assays for identifying disease subtypes has significant importance in precision medicine. However, computational limitations thwart this process due to the intricacy of the biological networks and the curse of dimensionality of gene expression data. Therefore, clustering in such scenarios often becomes the first choice of exploratory data analysis to identify natural structures and intrinsic patterns in the data. However, sparse and high dimensional nature of omics data prevents conventional clustering algorithms to discover subtypes that are clinically relevant and statistically significant. Hence, non-linear dimensionality reduction coupled with clustering in such scenarios often becomes imperative to improve the clustering results. In this study, we present a robust pipeline to discover disease subtypes with clinical relevance. Specifically, we focus on discovering patient sub-groups that have a residual life patterns remarkably different from other sub-groups. This is significant because by refining prognosis, subtyping can reduce uncertainty in approximating patients expected outcome. The methodology present is based on robust correlation estimation , UMAP – a non-linear dimensionality reduction method and mapper – a tool from topology. Notably, we suggest a method for improving the robustness of the correlation matrix of gene expression data for improving the clustering results. The performance of the model is evaluated by applying to five cancer datasets obtained through TCGA and comparisons are performed with some state of the art methods of NEMO, RSC-OTRI and SNF with regard to log−rank test and Restricted Life Expectancy Difference . For example in GBM dataset, the minimum separation for any two discovered subtypes is 221 days which is significantly higher than the other methodologies. We also compared the results without using the robust correlation based estimate and observed that robust correlation improves separability between survival curves significantly. From the results we infer that our methodology performs better compared to other methodologies with regard to separating survival curves of patient sub-groups despite using single omics profiles of patients compared to multiple omics profiles of SNF and NEMO. Pathway over-representation analysis is performed on the final clustering results to investigate the biological underpinnings characterising each subtype.

Clustering Gene Expression Time Series with Coregionalization: Speed propagation of ALS

Increasing Power by Sharing Information from Genetic Background and Treatment in Clustering of Gene Expression Time Series

Exploring the cuproptosis-related molecular clusters in the peripheral blood of patients with amyotrophic lateral sclerosis

Decoding genetic and pathophysiological mechanisms in amyotrophic lateral sclerosis and primary lateral sclerosis: A comparative study of differentially expressed genes and implicated pathways in motor neuron disorders

Functional regression clustering with multiple functional gene expressions

Key Molecules and Pathways Underlying Sporadic Amyotrophic Lateral Sclerosis: Integrated Analysis on Gene Expression Profiles of Motor Neurons

Quantitative trait associated microarray gene expression data analysis

Novel Insight Into the Role of Immune Dysregulation in Amyotrophic Lateral Sclerosis Based on Bioinformatic Analysis

A Special Local Clustering Algorithm for Identifying the Genes Associated with Alzheimer's Disease

Analyses of the Similarity and Difference of Global Gene Expression Profiles in Cortex Regions of Three Neurodegenerative Diseases: Sporadic Creutzfeldt-Jakob Disease (scjd), Fatal Familial Insomnia (FFI), and Alzheimer’s Disease (AD)

Gene expression profiles and protein-protein interaction networks in amyotrophic lateral sclerosis patients with C9orf72 mutation

Robust correlation estimation and UMAP assisted topological analysis of omics data for disease subtyping

Clustering of Alzheimer’s and Parkinson’s disease based on genetic burden of shared molecular mechanisms

Analysis of a Gibbs sampler method for model based clustering of gene expression data

Identifying Candidate Genes Associated with Sporadic Amyotrophic Lateral Sclerosis Via Integrative Analysis of Transcriptome-Wide Association Study and Messenger RNA Expression Profile

Integrated temporal profiling of iPSCs-derived motor neurons from ALS patients carrying C9orf72, FUS, TARDBP, and SOD1 mutations

Amyotrophic Lateral Sclerosis Genetic Studies

Comparison of Clustering Methods for Time Course Genomic Data: Applications to Aging Effects

Morbigenous Brain Region and Gene Detection with a Genetically Evolved Random Neural Network Cluster Approach in Late Mild Cognitive Impairment.

Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data

Interpolation based consensus clustering for gene expression time series